HUM 📈 Humana - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4448591028

HUM: Medical Insurance, Specialty Insurance, Pharmacy Benefits, Home Care Services

Humana Inc. is a leading health insurance company in the United States, offering a wide range of medical and specialty insurance products to individuals, employers, and government agencies. Through its two main segments, Insurance and CenterWell, the company provides a diverse portfolio of health insurance plans, including medical, supplemental, and specialty benefits.

The company's insurance products cater to various demographics, including individuals, seniors, and military personnel. For instance, Humana has a contract with the Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program. Additionally, it partners with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Humana's commercial insurance offerings include fully-insured medical and specialty health insurance benefits, such as dental, vision, and life insurance, as well as administrative services only products. The company also provides military services, including the TRICARE T2017 East Region contract. Furthermore, it operates a pharmacy benefit manager business, which helps manage prescription drug benefits for its members.

In addition to its insurance products, Humana operates a network of pharmacies and senior-focused primary care centers, offering convenient access to healthcare services for its members. The company also provides home solutions services, including home health, hospice, and other services, to both its health plan members and third-party clients.

Humana's products are sold through a variety of channels, including employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. This diversified distribution network enables the company to reach a broad customer base across the United States.

Founded in 1961, Humana Inc. is headquartered in Louisville, Kentucky, and has a rich history of providing innovative health insurance solutions to its members. Today, the company is a leading player in the US health insurance market, with a strong commitment to improving the health and well-being of its members.

For more information about Humana Inc. and its products, please visit its website at https://www.humana.com.

Additional Sources for HUM Stock

HUM Stock Overview

Market Cap in USD 35,896m
Sector Healthcare
Industry Healthcare Plans
GiC Industry Health Care Providers & Services
TER 0.00%
IPO / Inception 1993-01-22

HUM Stock Ratings

Growth 5y -20.2%
Fundamental 17.1%
Dividend 43.9%
Rel. Performance Sector -6.35
Analysts 3.52/5
Fair Price Momentum 253.93 USD
Fair Price DCF 639.64 USD

HUM Dividends

Dividend Yield 12m 1.52%
Yield on Cost 5y 1.32%
Annual Growth 5y 9.98%
Payout Consistency 53.77%

HUM Growth Ratios

Growth Correlation 3m -32.3%
Growth Correlation 12m -66.6%
Growth Correlation 5y 13.7%
CAGR 5y -2.80%
CAGR/Mean DD 5y -0.20
Sharpe Ratio 12m -1.27
Alpha -73.38
Beta 0.94
Volatility 51.41%
Current Volume 1046.1k
Average Volume 20d 1860.3k
What is the price of HUM stocks?
As of December 04, 2024, the stock is trading at USD 291.13 with a total of 1,046,060 shares traded.
Over the past week, the price has changed by -1.51%, over one month by +13.92%, over three months by -19.69% and over the past year by -40.25%.
Is Humana a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Humana is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 17.08 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HUM as of December 2024 is 253.93. This means that HUM is currently overvalued and has a potential downside of -12.78%.
Is HUM a buy, sell or hold?
Humana has received a consensus analysts rating of 3.52. Therefor, it is recommend to hold HUM.
  • Strong Buy: 6
  • Buy: 1
  • Hold: 18
  • Sell: 0
  • Strong Sell: 0
What are the forecast for HUM stock price target?
According to ValueRays Forecast Model, HUM Humana will be worth about 277.9 in December 2025. The stock is currently trading at 291.13. This means that the stock has a potential downside of -4.56%.
Issuer Forecast Upside
Wallstreet Target Price 288.2 -1%
Analysts Target Price 587.5 101.8%
ValueRay Target Price 277.9 -4.6%